- Home
- BKU vs SNY Comparison
BKU vs SNY Comparison
Compare BKU & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKU | SNY |
|---|---|---|
| Founded | 2009 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 119.4B |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | BKU | SNY |
|---|---|---|
| Price | $45.86 | $48.69 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 5 |
| Target Price | $42.92 | ★ $61.50 |
| AVG Volume (30 Days) | 984.0K | ★ 2.6M |
| Earning Date | 01-21-2026 | 01-29-2026 |
| Dividend Yield | 2.68% | ★ 3.28% |
| EPS Growth | 44.85 | ★ 105.93 |
| EPS | 3.54 | ★ 8.67 |
| Revenue | $1,016,093,000.00 | ★ $53,890,648,839.00 |
| Revenue This Year | $14.68 | $2.48 |
| Revenue Next Year | $5.73 | $6.47 |
| P/E Ratio | $13.07 | ★ $5.61 |
| Revenue Growth | ★ 10.45 | N/A |
| 52 Week Low | $28.21 | $44.62 |
| 52 Week High | $46.56 | $60.12 |
Technical Indicators
Market Signals| Indicator | BKU | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 74.04 | 43.35 |
| Support Level | $44.71 | $47.80 |
| Resistance Level | $45.11 | $49.24 |
| Average True Range (ATR) | 0.97 | 0.64 |
| MACD | 0.21 | -0.16 |
| Stochastic Oscillator | 88.58 | 29.77 |
Price Performance
Historical ComparisonAbout BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.